Inogen, Inc. (NASDAQ:INGN) Short Interest Down 16.1% in March

by · The Cerbat Gem

Inogen, Inc. (NASDAQ:INGN – Get Free Report) was the recipient of a significant drop in short interest in the month of March. As of March 31st, there was short interest totalling 662,900 shares, a drop of 16.1% from the March 15th total of 790,000 shares. Based on an average daily volume of 336,200 shares, the short-interest ratio is presently 2.0 days. Currently, 2.8% of the company’s stock are short sold.

Institutional Investors Weigh In On Inogen

Several hedge funds and other institutional investors have recently made changes to their positions in INGN. State Street Corp increased its stake in Inogen by 2.8% in the third quarter. State Street Corp now owns 511,018 shares of the medical technology company’s stock valued at $4,957,000 after purchasing an additional 14,054 shares during the last quarter. Barclays PLC grew its position in shares of Inogen by 72.9% in the 3rd quarter. Barclays PLC now owns 55,508 shares of the medical technology company’s stock valued at $539,000 after buying an additional 23,398 shares during the last quarter. Geode Capital Management LLC raised its stake in Inogen by 1.1% during the 3rd quarter. Geode Capital Management LLC now owns 554,191 shares of the medical technology company’s stock worth $5,377,000 after acquiring an additional 5,921 shares in the last quarter. Virtu Financial LLC purchased a new stake in Inogen in the third quarter valued at $111,000. Finally, Franklin Resources Inc. acquired a new position in Inogen in the third quarter valued at $139,000. Institutional investors and hedge funds own 89.94% of the company’s stock.

Analyst Upgrades and Downgrades

A number of equities analysts have recently commented on the company. Needham & Company LLC reissued a “hold” rating on shares of Inogen in a research report on Wednesday, April 9th. StockNews.com downgraded shares of Inogen from a “buy” rating to a “hold” rating in a research note on Wednesday, February 26th.

Check Out Our Latest Analysis on Inogen

Inogen Trading Down 2.1 %

NASDAQ:INGN traded down $0.15 during trading hours on Monday, hitting $6.68. The company’s stock had a trading volume of 9,793 shares, compared to its average volume of 238,976. The stock has a market capitalization of $179.47 million, a P/E ratio of -2.99 and a beta of 1.48. The stock has a fifty day moving average of $7.94 and a 200-day moving average of $9.14. Inogen has a 52-week low of $6.40 and a 52-week high of $13.33.

Inogen Company Profile

(Get Free Report)

Inogen, Inc, a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions.

Read More